{"changeSha256":"c3ab4bc89ee3ea96d3f597a5a31376ca3e25bd47cf13f54f5681aa63003cad53","changedAt":"2026-11-14","changedFields":[{"after":"A nine-amino-acid peptide, also called DSIP, that is not FDA-approved. FDA’s 2026 review found its human studies small and inconclusive.","before":"A peptide also called DSIP in FDA briefing material for a 2026 pharmacy-compounding advisory-committee meeting.","field":"Profile summary"},{"after":"FDA staff recommended in 2026 against adding emideltide or emideltide acetate to the 503A compounding list. Emideltide is not among the six peptides in HHS’s October 2026 draft enforcement-discretion policy.","before":"FDA's July 2026 briefing evaluates Emideltide-related bulk drug substances for pharmacy compounding. The briefing is an advisory-process assessment, not a final regulatory determination.","field":"Evidence note"},{"after":"DSIP, Delta sleep-inducing peptide","before":"DSIP","field":"Related names"},{"after":"fda-emideltide-briefing, fda-pcac-peptide-meeting-2026, federal-register-2026-07361-0aed508462b2, fda-bulk-peptide-risks, hhs-503a-peptide-enforcement-discretion-notice-2026, hhs-503a-peptide-enforcement-discretion-policy-2026","before":"fda-emideltide-briefing, fda-pcac-peptide-meeting-2026","field":"Cited source records"},{"after":"U.S. Food and Drug Administration [sources: fda-emideltide-briefing, fda-pcac-peptide-meeting-2026]; U.S. Department of Health and Human Services [sources: hhs-503a-peptide-enforcement-discretion-notice-2026]","before":"U.S. Food and Drug Administration [sources: fda-emideltide-briefing, fda-pcac-peptide-meeting-2026]","field":"Named organizations"},{"after":"name: fda-emideltide-briefing; aliases: fda-emideltide-briefing; category: fda-emideltide-briefing, fda-pcac-peptide-meeting-2026; status: fda-emideltide-briefing; summary: fda-emideltide-briefing; evidenceNote: fda-emideltide-briefing, hhs-503a-peptide-enforcement-discretion-policy-2026","before":"name: fda-emideltide-briefing; aliases: fda-emideltide-briefing; category: fda-emideltide-briefing, fda-pcac-peptide-meeting-2026; status: fda-emideltide-briefing; summary: fda-emideltide-briefing, fda-pcac-peptide-meeting-2026; evidenceNote: fda-emideltide-briefing","field":"Claim citations"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/emideltide/versions/3/","version":3},"id":"profile:emideltide:v3","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"profile-updated","notice":"We added a plain-language reader guide with cited answers, re-checked FDA’s emideltide briefing and compounding safety-risk page, and noted that HHS’s October 30, 2026 draft enforcement-discretion policy does not include emideltide.","peptideSlugs":["emideltide"],"previousChangeEvent":{"path":"/corrections/v1/profiles/emideltide/v2.json","sha256":"aaf172b9792d54624a0ecb209a83c3e2b3e194a6bfacc5fc3288b00ce34c650e"},"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/emideltide/versions/2/","version":2},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"fda-emideltide-briefing","name":"U.S. Food and Drug Administration","sourceClass":"A","title":"FDA briefing document for emideltide (DSIP) (free base) and emideltide acetate","url":"https://www.fda.gov/media/193344/download","verifiedAt":"2026-07-29"},{"id":"fda-bulk-peptide-risks","name":"U.S. Food and Drug Administration","sourceClass":"A","title":"Certain bulk drug substances for use in compounding that may present significant safety risks","url":"https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks","verifiedAt":"2026-11-14"},{"id":"hhs-503a-peptide-enforcement-discretion-policy-2026","name":"U.S. Department of Health and Human Services","sourceClass":"A","title":"HHS Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances, with Appendix A (list of peptides) and Appendix B (identities and justifications)","url":"https://www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy-appendix-b.pdf","verifiedAt":"2026-11-14"}],"subject":{"slug":"emideltide","type":"profile"}}
